Table 2 GH supplementation, gonadotropin dosage and the change in hormone levels
Characteristic | GH group (n = 51) | Control group (n = 53) | P value |
|---|---|---|---|
Total dose of rhGH (IU) | 120.7 ± 28.90 |  |  |
Median duration of GH supplementation (Day) | 52.4 ± 19.04 |  |  |
FSH (mIU/ml) | Â | Â | Â |
 on the initiation day of Gn | 6.035 ± 1.5517 | 6.638 ± 1.7685 | 0.053 |
 the change from baseline | -0.306 ± 1.5138 | 0.324 ± 1.6585 | 0.0458 |
LH (mIU/ml) | Â | Â | Â |
 on the initiation day of Gn | 3.926 ± 1.7738 | 4.704 ± 1.5462 | 0.0017 |
 the change from baseline | -0.094 ± 3.4831 | 1.127 ± 1.5142 | 0.0134 |
E2 (pg/ml) | Â | Â | Â |
 on HCG day | 2844.112 ± 1244.9055 | 2735.585 ± 1071.3677 | 0.6773 |
 the change from baseline | 2812.400 ± 1245.3048 | 2700.510 ± 1071.4906 | 0.6631 |
Progesterone (pg/ml) | Â | Â | Â |
 on HCG day | 0.9386 ± 0.5157 | 1.2362 ± 0.6094 | 0.0098 |
 the change from baseline | 0.5595 ± 0.8020 | 0.9054 ± 0.6505 | 0.0219 |
IGF-1 (ng/ml) | Â | Â | Â |
 on the day of oocyte retrieval | 208.998 ± 60.7129 | 185.958 ± 73.7515 | 0.027 |
 the change from baseline | 19.895 ± 54.3752 | -16.033 ± 68.0917 | 0.0006 |
Total Gn dosage (IU) | 2213.24 ± 667.015 | 2573.32 ± 630.009 | 0.0058 |
Duration of Gn (Day) | 10.1 ± 1.60 | 10.6 ± 1.30 | 0.0488 |